Medical Devices Startups

Innovative Health is an FDA-regulated single-use medical device reprocessing company specializing in cardiology and electrophysiology devices, gaining FDA clearance to reprocess and resell used catheters and other single-use devices. It serves hospitals in the United States, helping electrophysiology labs cut per-procedure device costs, such as those for atrial fibrillation treatments, by roughly 30%.

0 investors

Innovotex develops macrocycle-mediated targeted delivery systems for cancer therapies, building multi-modal platforms intended to improve the effectiveness of targeted cancer treatments. The company operates in oncology-focused therapeutics.

0 investors

Insightra Medical develops intra-aortic balloon pump (IABP) catheters used to temporarily support heart function, including a 7Fr IAB catheter kit compatible with Arrow and Datascope consoles. The products are FDA-cleared medical devices intended for use by medical professionals in cardiac catheterization settings.

0 investors

Instrumentum provides outsourced sterile processing and sterilization services to healthcare systems and surgical centers, enabling them to scale surgical volume without requiring internal infrastructure expansion.

0 investors

iEscope manufactures single-use surgical arthroscopes for orthopedic procedures, offering sterile, pre-assembled optical instruments that eliminate traditional sterilization and maintenance costs. The company serves surgical centers and hospitals seeking reliable backup instrumentation with consistent image quality across all operating room settings.

0 investors

Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company that makes non-invasive drug testing products, including a fingerprint sweat analysis screening system and the SmarTest wearable sweat patch, to detect recent and longer-term drug use. Its products serve justice, rehabilitation, and workplace drug-screening markets and are sold across 35 countries while pursuing FDA clearance for U.S. entry.

0 investors

Intent Solutions builds technology to improve the administration and monitoring of prescription drugs, with a focus on addressing the opioid crisis. The company operates in healthcare technology and medical devices.

0 investors

Intuitive Bio develops Colony Surveillance Assays (CSA), diagnostic kits for screening laboratory animal colonies for exposure to specific pathogens. The kits are designed for research institutions and breeding facilities requiring pathogen-free colony verification.

0 investors

IntuitiveX is a medical innovation and venture group focused on healthcare and medical technology, bringing together clinicians, scientific advisors, and IP and business specialists to develop and commercialize products. Its team spans orthopedic, spine, cardiology, and neurosurgery expertise alongside intellectual property strategy and investment support.

0 investors

IonDX develops analytical instrumentation for biomacromolecules and nanomaterials analysis, drawing on decades of expertise in mass spectrometry and X-ray crystallography methods. The company serves life sciences researchers and biotech organizations requiring advanced analytical tools.

0 investors

iOncologi develops immunotherapy platforms designed to treat cancer by priming the immune system to attack tumors and overcoming immune resistance. The company's proprietary technologies target solid tumors and refractory cancers through personalized immune conditioning and cell-based approaches.

0 investors

IONETIX manufactures radiopharmaceuticals and operates a network of compact superconducting cyclotrons for PET imaging and cancer therapy production. The company produces N-13 Ammonia tracers for cardiac imaging and targeted alpha therapy radiopharmaceuticals for oncology applications.

0 investors

IR Medtek develops infrared spectroscopy technology combined with machine learning for non-invasive detection of skin cancer. The company applies mid-infrared imaging and data analysis methods to give physicians diagnostic tools for solid tumors.

0 investors

IrisVision builds wearable, hands-free electronic low vision aids that magnify and enhance vision, along with personalized coaching, for people living with conditions such as macular degeneration, diabetic retinopathy, retinitis pigmentosa, and Stargardt disease. Developed with vision scientists and supported by NIH research, it operates at the intersection of digital health and vision science and is a Skipfour product.

0 investors

Irving Specialists Surgical Center is an outpatient surgical facility providing specialized surgical procedures in a personalized environment. The center operates with modern technology and a trained surgical team focused on patient safety and efficient care coordination.

0 investors

The page presents team members affiliated with Cambrian Bio, describing roles in R&D project management, business operations, and medicinal chemistry consulting within drug discovery and development. The individuals have backgrounds in developing medicines and small-molecule therapeutics across pharma and biotech.

0 investors

iTolerance develops the SA-FasL microgel (iTOL-100) immunomodulatory technology aimed at enabling cell and tissue transplantation, such as insulin-producing islet cells for diabetes, without continuous anti-rejection drugs. The company operates in regenerative medicine and transplantation immunology.

0 investors

iVeena Delivery Systems is a clinical-stage ophthalmology company developing pharmacologic eye-drop therapies for refractive eye diseases, including IVMED-80 for keratoconus and IVMED-85 for pediatric myopia. Its lead keratoconus asset has been licensed to Glaukos Corporation.

0 investors

ivWatch develops sensors and monitoring systems that detect peripheral IV infiltrations and extravasations at early stages to prevent patient harm in hospital settings. The company serves healthcare providers and hospitals globally through direct partnerships and a network of distributors.

0 investors

J3 Bio develops an FDA-cleared intravaginal ring platform called LivRing for delivering active and functional ingredients to address women's health needs across multiple conditions and life stages. The company targets the direct-to-consumer women's health market with clinically validated solutions designed for accessibility outside traditional medical channels.

0 investors

Jana Care offers a smartphone-enabled at-home blood testing system using its Aina device, paper test strips, and a mobile app to detect key biomarkers for chronic disease management. Its platform serves patients, caregivers, and clinicians by sharing clinically-relevant results in real time for conditions such as heart failure and kidney disease.

0 investors

Jupiter Biomedical Research is a drug development company with patents for two therapeutic candidates: JBR-102, an oral treatment for glioblastoma multiforme and other brain tumors, and JBR-201, an antiviral treatment for measles virus infections and related neurological diseases. The company is pursuing regulatory approval from Health Canada and the FDA for its lead cancer candidate while advancing preclinical development of its antiviral program.

0 investors

K Medical is a healthcare startup developing simple, effective medical solutions, with a current focus on preventing bedsores (pressure ulcers). The company's work is supported by NIH STTR and SBIR grants and conducted in collaboration with academic experts in compliant mechanisms and assistive technologies.

0 investors

Kairos Pharma is a clinical-stage biopharmaceutical company developing therapies to overcome resistance to cancer drugs and reverse cancer-induced immune suppression. Its pipeline includes ENV105, a CD105 antibody in Phase 2 prostate cancer and Phase 1 lung cancer trials, and immunotherapy candidates KROS101 and KROS201 for oncology indications including glioblastoma.

0 investors